# FutureFuel Corp.: Form 10-Q for the period ended Sep 30, 2010

- Company: [FutureFuel Corp.](/companies/ff.md) (CIK 1337298)
- Form: 10-Q
- Filed: 2010-11-05
- Accepted by EDGAR: Nov 5, 2010, 13:30 ET
- Period: 2010-09-30
- Accession: 0001068800-10-000094
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1337298/000106880010000094/future10q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1337298/000106880010000094/

## Management's discussion and analysis

As filed, 32,910 characters.

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read together with our consolidated financial statements, including the notes thereto, set forth herein. This discussion contains forward-looking statements that reflect our current views with respect to future events and financial performance. Actual results may differ materially from those anticipated in these forward-looking statements. See “Forward Looking Information” below for additional discussion regarding risks associated with forward-looking statements.

#### Results of Operations

#### In General

We break our chemicals business into two main product groups: custom manufacturing and performance chemicals. Custom manufacturing consists of products made for specific customers based upon specifications provided by such customers. Major products in the custom manufacturing group include: (i) nonanoyloxybenzenesulfonate, a bleach activator manufactured exclusively for The Procter & Gamble Company for use in a household detergent; and (ii) a proprietary herbicide (and intermediates) manufactured exclusively for Arysta LifeScience North America Corporation. The custom manufacturing group also includes agrochemicals as well as industrial and consumer products (cosmetics and personal care products, ink colorants, adhesion promoters, polymer additives, polymer and specialty dyes, specialty polymers, photographic and imaging chemicals, and food additives).

Revenues generated from the bleach activator are based on a supply agreement with the customer. The supply agreement stipulates selling price per kilogram based on volume sold, with price moving up as volumes move down, and vice-versa. We pay for raw materials required to produce the bleach activator. The contract with the customer provides that the price received by us for the bleach activator is indexed to changes in certain items, enabling us to pass along most inflationary increases in production costs to the customer.

We have been the primary manufacturer for the customer of the proprietary herbicide and intermediates. These products are facing generic competition, and no assurances can be given that we will remain the primary manufacturer for this product line. No assurances can be given that the demand for these products will continue or that these contracts will not be terminated. The customer supplies most of the key raw materials for production of the proprietary herbicide. There is no pricing mechanism or specific protection against cost changes for raw materials or conversion costs that we are responsible for purchasing and/or providing.

Pricing for the other custom manufacturing products is negotiated directly with the customer. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes.

Performance chemicals consists of specialty chemicals that are manufactured to general market-determined specifications and are sold to a broad customer base. The major product line in the performance chemicals group is SSIPA/LiSIPA, a polymer modifier that aids the properties of nylon. This group of products also includes sulfonated monomers and hydrotropes, specialty solvents, polymer additives, and chemical intermediates.

SSIPA/LiSIPA revenues are generated from a diverse customer base of nylon fiber manufacturers and other customers that produce condensation polymers. Contract sales are indexed to key raw materials for inflation; otherwise, there is no pricing mechanism or specific protection against raw material or conversion cost changes.

Pricing for the other performance chemicals products is established based upon competitive market conditions. Some, but not all, of these products have pricing mechanisms and/or specific protections against raw material or conversion cost changes.

We procure all of our own feedstock and only sell biodiesel for our own account. In rare instances, we purchase biodiesel from other producers for resale. We have the capability to process multiple types of vegetable oils and animal fats, we can receive feedstock by rail or truck, and we have completed the construction of substantial storage capacity to acquire feedstock at advantaged prices when market conditions permit. In 2009, we completed a project to increase our production capacity to 59 million gallons of biodiesel per year through the addition of a new continuous processing line. We initiated commercial production from this new line in May 2009. By the end of the second quarter of 2009, daily production volumes from the new processing line were demonstrated at approximately 80% of nameplate capacity. This production line was designed to produce biodiesel from feedstock with low fatty acids. We believe we successfully demonstrated our ability to keep this continuous processing line at or near capacity for sustained periods of time as well as our ability to both procure and logistically handle large quantities of feedstock with low fatty acids. However, with the expiration of the $1.00 federal blender’s credit at the end of 2009, we determined that feedstock with low fatty acids were too costly to consistently produce biodiesel with positive margins. Accordingly, we redesigned our continuous line to produce biodiesel from feedstock with high fatty acids. We are still in the process of debugging this redesigned line.

There currently is uncertainty as to whether we will produce biodiesel in the future. This uncertainty results from: (i) changes in feedstock prices relative to biodiesel prices; (ii) the $1.00 per gallon federal blender’s tax credit, which credit terminated on December 31, 2009 and has not been renewed; and (iii) the permanency of government mandates. See “Risk Factors” below.

The majority of our expenses are cost of goods sold. Cost of goods sold includes raw material costs as well as both fixed and variable conversion costs, conversion costs being those expenses that are directly or indirectly related to the operation of our plant. Significant conversion costs include labor, benefits, energy, supplies, depreciation, and maintenance and repair. In addition to raw material and conversion costs, cost of goods sold includes environmental reserves and costs related to idle capacity. Finally, cost of goods sold includes hedging gains and losses recognized by us related to our biofuels segment. Cost of goods sold is allocated to the chemical and biofuels business segments based on equipment and resource usage for most conversion costs and based on revenues for most other costs.

The discussion of results of operations that follows is based on revenues and expenses in total and for individual product lines and does not differentiate related party transactions.

#### Three Months Ended September 30, 2010 Compared to Three Months Ended September 30, 2009

*Revenues:* Revenues for the three months ended September 30, 2010 were $66,093,000 as compared to revenues for the three months ended September 30, 2009 of $52,263,000, an increase of 26%. Revenues from biofuels increased 43% and accounted for 29% of total revenues in 2010 as compared to 25% in 2009. Revenues from chemicals increased 21% and accounted for 71% of total revenues in 2010 as compared to 75% in 2009.

Revenues from the bleach activator and the proprietary herbicide and intermediates are together the most significant components of our revenue base, accounting for 47% of revenues for the three months ended September 30, 2010 as compared to 55% for the three months ended September 30, 2009. Revenue from the bleach activator increased 15% from the third quarter of 2009 to the third quarter of 2010 as a result of overall improved worldwide economic conditions. The future volume of and revenues from the bleach activator depend on both consumer demand for the product containing the bleach activator and the manufacturing, sales, and marketing priorities of our customer. We are unable to predict with certainty the revenues we will receive from this product in the future. With respect to the proprietary herbicide and intermediates, revenues did not change materially from the third quarter of 2009 to the third quarter of 2010. Expectations are that the demand will remain strong in the foreseeable future.

Revenues from other custom manufacturing chemical products increased 67% in the third quarter of 2010 as compared to the third quarter of 2009. This increase was almost entirely driven by increased demand for most of our existing smaller custom manufactured chemicals (mainly our various industrial intermediates) combined with a substantial increase in revenues generated under new custom chemical manufacturing agreements (those less than one year old). Revenues from performance chemicals increased approximately 9% in the third quarter of 2010 as compared to the third quarter of 2009. We expect demand to remain constant for the foreseeable future.

Increased revenues in the third quarter of 2010 from the biofuels segment resulted from increased volumes of petrodiesel and biodiesel sold in the third quarter of 2010 as compared to the third quarter of 2009 and increased sales prices of both products. The volume increase was a result of success with our regional fuel distribution strategy. The increase in revenues from biodiesel was partially offset by the expiration of the $1.00 per gallon federal blender’s credit at the end of 2009. A substantial portion of our biodiesel sold in the third quarter of 2010 was to a major refiner in the United States. However, no assurances can be given that we will continue to sell to such major refiner or, if we do sell, the volume that will be sold. In the event the $1.00 per gallon federal blender’s credit is reinstated retroactive to January 1, 2010, we will be eligible for a credit of approximately $6,000,000 at September 30, 2010. However, no assurances can be given that such credit will be reinstated or, if reinstated, that it will be reinstated retroactively.

We purchased a granary in March 2009 and, because we anticipate future synergies with our biofuels business, we include the granary’s operating results in our biofuels segment. Granary revenues are generated from the sale of agricultural commodities, primarily soybeans, milo, and corn.

*Cost of Goods Sold and Distribution:* Total cost of goods sold and distribution for the three months ended September 30, 2010 were $54,217,000 as compared to total cost of goods sold and distribution for the three months ended September 30, 2009 of $38,613,000, an increase of 40%.

Cost of goods sold and distribution for the three months ended September 30, 2010 for our chemicals segment were $33,920,000 as compared to cost of goods sold and distribution for the three months ended September 30, 2009 of $31,100,000. On a percentage basis, the 9% increase in cost of goods sold and distribution was less than the 21% increase in chemicals segment revenues. The primary difference between these figures was a result of shifts in product mix from 2009 to 2010, as well as a LIFO reduction as of September 30, 2010.

Cost of goods sold and distribution for the third quarter of 2010 for our biofuels segment were $20,297,000 as compared to cost of goods sold and distribution for the third quarter of 2009 of $7,513,000. On a percentage basis, cost of goods sold and distribution increased 170% versus an increase in revenues of 43%. Declines in margins and losses in our biofuels segment for the third quarter of 2010 were primarily a direct result of expiration of the $1.00 per gallon federal blender’s credit. We continued acquiring feedstock and producing biodiesel during the third quarter of 2010 in anticipation of renewal of the credit. However, because of continued delays in renewing the blender’s credit, we were forced to suspend both production and procurement of feedstock. Partially offsetting reduced margins from biodiesel was continued growth of our fuel distribution business through which we sell petrodiesel and biodiesel blends of less than 5% to as much as 99.9%.

*Operating Expenses:* Operating expenses increased 3% from $2,265,000 for the three months ended September 30, 2009 to $2,340,000 for the three months ended September 30, 2010. Compensation expense increased 11%, primarily as a result of accrued bonuses. Other expense increased 82% from $382,000 for the three months ended September 30, 2009 to $697,000 for the three months ended September 30, 2010. Related party expense decreased 19% as a result of reduced travel. Finally, research and development expense decreased 28% from $1,111,000 in the third quarter of 2009 to $800,000 in the third quarter of 2010; this decrease was the result of reduced efforts in certain projects.

*Provision for Income Taxes:* The effective tax rates for the three months ended September 30, 2010 and 2009 reflect our expected tax rate on reported operating earnings before income taxes. We have determined that we do not believe that we have a more likely than not probability of realizing a portion of our deferred tax assets. As such, we have recorded a valuation allowance of $690,000 at September 30, 2010.

#### Nine Months Ended September 30, 2010 Compared to Nine Months Ended September 30, 2009

*Revenues:* Revenues for the nine months ended September 30, 2010 were $165,570,000 as compared to revenues for the nine months ended September 30, 2009 of $133,831,000, an increase of 24%. Revenues from biofuels increased 11% and accounted for 20% of total revenues in 2010 as compared to 23% in 2009. Revenues from chemicals increased 28% and accounted for 80% of total revenues in 2010 as compared to 77% in 2009.

Revenues from the bleach activator and the proprietary herbicide and intermediates are together the most significant components of our revenue base, accounting for 52% of revenues for the nine months ended September 30, 2010 as compared to 58% for the nine months ended September 30, 2009. Revenues from the bleach activator increased 12% during the first nine months of 2010 as a result of overall improved worldwide economic conditions. The future volume of and revenues from the bleach activator depend on both consumer demand for the product containing the bleach activator and the manufacturing, sales, and marketing priorities of our customer. We are unable to predict with certainty the revenues we will receive from this product in the future. With respect to the proprietary herbicide and intermediates, revenues increased 13% in the first nine months of 2010 as compared to 2009 as a result of increased volumes and, to a lesser extent, a higher priced product mix. We expect demand to remain constant for the foreseeable future.

Revenues from other custom manufacturing chemical products increased 91% in the first nine months of 2010 as compared to the first nine months of 2009. Revenues were up in the first nine months of 2010 for nearly all of our custom and performance chemical products. In particular, the revenue increase was driven by increased demand for our various industrial intermediates combined with a substantial increase in revenues generated under new custom chemical manufacturing agreements (those less than one year old). Revenues from performance chemicals increased approximately 21% in the first nine months of 2010 as compared to 2009 as a result of new products added to our portfolio. We expect demand to remain constant for the foreseeable future.

Increased revenues in the third quarter of 2010 from the biofuels segment resulted from increased volumes of petrodiesel and biodiesel sold in the third quarter of 2010 as compared to the third quarter of 2009 and from increased sales prices of both products. The volume increase was a result of success with our regional fuel distribution strategy. The increase in revenues from biodiesel was partially offset by reduced demand resulting from the expiration of the $1.00 per gallon federal blender’s credit at the end of 2009. A substantial portion of our biodiesel sold in the first nine months of 2010 was to a major refiner in the United States. However, no assurances can be given that sales to such major refiner will continue or, if they do continue, the volume of such sales. In the event the $1.00 per gallon federal blender’s credit is reinstated retroactive to January 1, 2010, we will be eligible for a credit of approximately $6,000,000 at September 30, 2010. However, no assurances can be given that such credit will be reinstated or, if reinstated, that it will be reinstated retroactively.

We purchased a granary in March 2009 and, because we anticipate future synergies with our biofuels business, we include the granary’s operating results in our biofuels segment. Granary revenues are generated from the sale of agricultural commodities, primarily soybeans, milo, and corn.

*Cost of Goods Sold and Distribution:* Total cost of goods sold and distribution for the first nine months of 2010 were $139,451,000 as compared to total cost of goods sold and distribution for 2009 of $107,953,000, an increase of 29%.

Cost of goods sold and distribution for the first nine months of 2010 for our chemicals segment were $99,845,000 as compared to cost of goods sold and distribution for the first nine months of 2009 of $81,110,000. On a percentage basis, the 23% increase in cost of goods sold and distribution mirrored the 28% increase in chemicals segment revenues.

Cost of goods sold and distribution for the first nine months of 2010 for our biofuels segment were $39,606,000 as compared to cost of goods sold and distribution for the first nine months of 2009 of $26,843,000. On a percentage basis, cost of goods sold and distribution increased 48% versus an increase in revenues of 11%. Declines in margins and losses in our biofuels segment for the first nine months of 2010 were a direct result of the expiration of the $1.00 per gallon federal blender’s credit. We continued acquiring feedstock and producing biodiesel during the first nine months of 2010 in anticipation of renewal of the credit. However, because of continued delays in renewing the blender’s credit, we were forced to suspend both production and procurement of feedstock. Partially offsetting reduced margins from biodiesel was continued growth of our fuel distribution business through which we sell petrodiesel and biodiesel blends of less than 5% to as much as 99.9%.

*Operating Expenses:* Operating expenses were essentially unchanged from $6,565,000 in the first nine months of 2009 to $6,563,000 in the first nine months of 2010. Compensation expense increased 12%, primarily as a result of additions to our chemical sales department, moderate increases in wages, and a full nine months of expense related to the granary as compared to just over three months in 2009. Other expense increased 25% from $1,278,000 in the first nine months of 2009 as compared to $1,602,000 in the first nine months of 2010. Related party expense decreased 33% as a result of reduced travel. Finally, research and development expense decreased 17% from $3,110,000 in the first nine months of 2009 to $2,586,000 in the first nine months of 2010; this decrease was the result of reduced efforts in certain projects.

*Provision for Income Taxes:* The effective tax rates for the nine months ended September 30, 2010 and 2009 reflect our expected tax rate on reported operating earnings before income taxes. We have determined that we do not believe that we have a more likely than not probability of realizing a portion of our deferred tax assets. As such, we have recorded a valuation allowance of $690,000 at September 30, 2010.

#### Critical Accounting Estimates

*Revenue Recognition:* For most product sales, revenue is recognized when product is shipped from our facilities and risk of loss and title have passed to the customer, which is in accordance with our customer contracts and the stated shipping terms. Nearly all custom manufactured products are manufactured under written contracts. Performance chemicals and biodiesel are sold pursuant to the terms of written purchase orders. In general, customers do not have any rights of return, except for quality disputes. However, all of our products are tested for quality before shipment, and historically returns have been inconsequential. We do not offer volume discounts, rebates, or warranties.

Revenue from bill and hold transactions in which a performance obligation exists is recognized when the total performance obligation has been met. Bill and hold transactions for five specialty chemical customers in 2009 and 2010 related to revenue that was recognized in accordance with contractual agreements based on product produced and ready for use. These sales were subject to written monthly purchase orders with agreement that production was reasonable. The inventory was custom manufactured and stored at the customer’s request and could not be sold to another buyer. Credit and payment terms for bill and hold customers are similar to other custom chemical customers. Sales revenue under bill and hold arrangements were $14,948,000 and $12,263,000 for the three months ended September 30, 2010 and 2009, respectively, and $41,412,000 and $30,281,000 for the nine months ended September 30, 2010 and 2009, respectively.

#### Liquidity and Capital Resources

Our consolidated net cash provided by (used in) operating activities, investing activities, and financing activities for the nine months ended September 30, 2010 and 2009 are set forth in the following chart.

(Dollars in thousands)

|  | Nine Months Ended September 30, 2010 | Nine Months Ended September 30, 2009 |
| --- | ---: | ---: |
| Net cash provided by operating activities | $17,509 | $15,457 |
| Net cash provided by (used in) investing activities | $(25,919) | $30,607 |
| Net cash provided by (used in) financing activities | $46,433 | $(385) |

*Operating Activities:* Cash provided by operating activities increased from $15,457,000 during the first nine months of 2009 to $17,509,000 during the first nine months of 2010. Cash provided by (used in) the change in deferred revenue increased from $(578,000) in the first nine months of 2009 to $5,252,000 in 2010. Certain customers reimbursed us for capital expenditures we incurred in the construction or modification of assets to produce new products. In addition, the State of Arkansas began funding a capital project to expand and improve the rail infrastructure at our site. These fundings by customers and the government were recognized as deferred revenue to be amortized over the expected life of the respective customer relationship or asset. Cash provided by (used in) the change in provision for deferred income taxes increased from $400,000 in the first nine months of 2009 to $2,889,000 in 2010. This increase relates to the difference in the timing of revenue and expense recognition for book and tax. Partially offsetting changes in cash provided by deferred revenue and provision for deferred income taxes was cash provided by (used in) the change in accounts receivable, which increased from $(3,086,000) for the first nine months of 2009 to $(5,091,000) for the first nine months of 2010. This increase in the change in accounts receivable was primarily from an increase in trade receivables. Also, partially offsetting changes in cash provided by deferred revenue and provision for deferred income taxes was cash provided by (used in) changes in income taxes payable/ receivable, which decreased from $3,368,000 in the first nine months of 2009 to $(609,000) in the first nine months of 2010. This change in cash generated from (used in) income taxes payable/receivable results from the timing of our tax payments; we had an income tax payable at September 30, 2009 whereas we had an income tax receivable at September 30, 2010.

*Investing Activities:* Cash provided by (used in) investing activities decreased from $30,607,000 in the first nine months of 2009 to $(25,919,000) in the first nine months of 2010. This decrease is attributable to changes in net cash flows from short-term investments, partially offset by lower capital expenditures. Cash provided by (used in) the purchase of marketable securities, the proceeds from the sale of marketable securities, the net purchases of auction rate securities, the proceeds from the sale of commercial paper, and the purchase of preferred stock, trust preferred securities, and master limited partnerships was $43,582,000 in the first nine months of 2009 as compared to $(18,866,000) in 2010. The investing activities which spurred these changes are further described below under “Capital Management”. Partially offsetting the reduction in cash flows from short-term investments, cash used for capital expenditures decreased from $17,177,000 in the first nine months of 2009 to $6,063,000 in 2010.

*Financing Activities:* Cash provided by (used in) financing activities increased from $(385) in the first nine months of 2009 to $46,433,000 in the first nine months of 2010. This change is attributable to $70,700,000 in proceeds from the issuance of stock in the first nine months of 2010 stemming from certain warrant holders exercising such warrants, partially offset by $1,210,000 used to purchase and cancel outstanding warrants and by $23,057,000 used to pay dividends in the first nine months of 2010.

#### Credit Facility

FutureFuel Chemical Company entered into a $50 million credit agreement with a commercial bank in March 2007. The loan is a revolving facility the proceeds of which may be used for working capital, capital expenditures, and general corporate purposes of FutureFuel Chemical Company. The facility terminates on June 30, 2013. Advances are made pursuant to a borrowing base. Advances are secured by a perfected first priority security interest in accounts receivable and inventory. The interest rate floats at certain margins over LIBOR or base rate dependent upon certain leverage ratios.

There is an unused commitment fee on 0.325% per annum. The ratio of EBITDA to fixed charges may not be less than 3:1. We have guaranteed FutureFuel Chemical Company’s obligations under this credit agreement.

As of September 30, 2010 and December 31, 2009, FutureFuel Chemical Company had no borrowings under this $50 million credit agreement.

We intend to fund future capital requirements for our chemical and biofuels segments from cash flow generated by operations as well as from existing cash and borrowings under the credit facility. We do not believe there will be a need to issue any securities to fund such capital requirements.

#### Off-Balance Sheet Arrangements

Our only off-balance sheet arrangements were hedging transactions. We engage in two types of hedging transactions. First, we hedge our biodiesel sales through the purchase and sale of futures contracts and options on futures contracts of energy commodities. This activity was captured on our balance sheet at September 30, 2010 and December 31, 2009. Second, we hedge our biodiesel feedstock through the execution of purchase contracts and supply agreements with certain vendors. These hedging transactions are recognized in earnings and were not recorded on our balance sheet at September 30, 2010 or December 31, 2009 as they do not meet the definition of a derivative instrument as defined under accounting principles generally accepted in the U.S. The purchase of biodiesel feedstock generally involves two components: basis and price. Basis covers any refining or processing required as well as transportation. Price covers the purchases of the actual agricultural commodity. Both basis and price fluctuate over time. A supply agreement with a vendor constitutes a hedge when we have committed to a certain volume of feedstock in a future period and have fixed the basis and/or price for that volume.

#### Capital Management

As a result of our initial equity offering and our subsequent positive operating results, we have accumulated excess working capital. Some of this excess working capital has been paid out as special cash dividends. We intend to retain the remaining cash to fund infrastructure and capacity expansion at our Batesville plant and to pursue complimentary acquisitions in the energy and chemical industries. Given the recent and current conditions in capital markets, we intend to take a risk averse approach to managing these funds. Third parties have not placed significant restrictions on our working capital management decisions.

In the third quarter of 2010, these funds were predominantly held in cash or cash equivalents at multiple financial institutions and, to a lesser degree, preferred stock, trust preferred securities, and master limited partnerships. We also maintained a small position in auction rate securities.

We have selectively made investments in certain auction rate securities that we believe offer sufficient yield along with sufficient liquidity. To date, all the auction rate securities in which we have invested have maintained a mechanism for liquidity, meaning that the respective auctions have not failed, the issuers have called the instruments, or a secondary market exists for liquidation of the securities. We have classified these instruments as current assets in the accompanying consolidated balance sheets and carry them at their estimated fair value. The fair value of these instruments approximated their par value and, including accrued interest, totaled $2,800,000 at September 30, 2010. Auction rate securities are typically long-term bonds issued by an entity for which there is a series of auctions over the life of the bond that serve to reset the interest rate on the bonds to a market rate. These auctions also serve as a mechanism to provide liquidity to the bond holders; as long as there are sufficient purchasers of the auction rate securities, the then owners of the auction rate securities are able to liquidate their investment through a sale to the new purchasers. In the event of an auction failure, a situation when there are more sellers than buyers of a particular issue, the current owners of an auction rate security issue may not be able to liquidate their investment. As a result of an auction failure, a holder may be forced to hold the particular security either until maturity or until a willing buyer is found. Even if a willing buyer is found, however, there is no guarantee that this willing buyer will purchase the security for its carrying value, which would result in a loss being realized on the sale. The liquidity problems currently experienced in the U.S. auction rate securities markets have generally been focused on closed-end fund and student loan auction rate securities, asset classes that we have avoided.

We maintain depository accounts such as checking accounts, money market accounts, and other similar accounts at selected financial institutions.

#### Other Matters

We entered into an agreement with a customer to construct, at a fixed price, a processing plant and produce a certain chemical for the customer. We engaged a third party to act as general contractor on the construction of this plant for a guaranteed price. That general contractor defaulted on its obligations under its contract with us and abandoned the project. As a result, we undertook the general contractor role ourselves. We also filed suit against our former contractor to recoup any damages that we may incur as a result of his default. The former contractor has counterclaimed against us for amounts he asserts are due him under our contract with him. At this time, we are unable to determine what effect the general contractor’s counterclaim will have on us or on our financial condition.

We entered into an agreement with a biodiesel trade association to pay certain fees and dues to the association in order to obtain access and registration to the association’s compiled biodiesel health effects data (“***HED”***) required by the United States Environmental Protection Agency (“***USEPA”***) for biodiesel manufacturers. Manufacturers of biodiesel who pay their fair share of costs for the HED can have access to and obtain registration with the USEPA. We brought suit against the trade association for rescission of the agreement for various reasons including, among other things, that we have already paid our fair share of costs for the data to the trade association; and that the fees and dues structure of the trade association are overly excessive and against public policy. The trade association has filed suit against us for collection of alleged fees and dues owed by us to it. At this time, we are unable to determine what effect the trade association’s suit against us will have on us or on our financial condition.

## Market risk

As filed, 4,233 characters.

In recent years, general economic inflation has not had a material adverse impact on our costs and, as described elsewhere herein, we have passed some price increases along to our customers. However, we are subject to certain market risks as described below.

Market risk represents the potential loss arising from adverse changes in market rates and prices. Commodity price risk is inherent in the chemical and biofuels businesses both with respect to input (electricity, coal, biofuel feedstock, etc.) and output (manufactured chemicals and biofuels).

We seek to mitigate our market risks associated with the manufacturing and sale of chemicals by entering into term sale contracts that include contractual market price adjustment protections to allow changes in market prices of key raw materials to be passed on to the customer. Such price protections are not always obtained, however, so raw material price risk remains significant.

In order to manage price risk caused by market fluctuations in biofuel prices, we may enter into exchange traded derivatives consisting of commodity futures and options contracts. We account for these derivative instruments in accordance with ASC 815-20-25, *Derivatives and Hedging, Hedging-General, Recognition.* Under this standard, the accounting for changes in the fair value of a derivative instrument depends upon whether it has been designated as an accounting hedging relationship and, further, on the type of hedging relationship. To qualify for designation as an accounting hedging relationship, specific criteria must be met and appropriate documentation maintained. We had no derivative instruments that qualified under these rules as designated accounting hedges in 2010 or 2009. Changes in the fair value of our derivative instruments are recognized at the end of each accounting period and recorded in the statement of operations as a component of cost of goods sold.

Our immediate recognition of derivative instrument gains and losses can cause net income to be volatile from quarter to quarter due to the timing of the change in value of the derivative instruments relative to the sale of biofuel being sold. As of September 30, 2010 and December 31, 2009, the fair values of our derivative instruments were a net liability in the amount of $3,187,000 and $1,930,000, respectively.

Our gross profit will be impacted by the prices we pay for raw materials and conversion costs (costs incurred in the production of chemicals and biofuels) for which we do not possess contractual market price adjustment protection. These items are principally comprised of animal fat and electricity. The availability and price of these items are subject to wide fluctuations due to unpredictable factors such as weather conditions, overall economic conditions, governmental policies, commodity markets, and global supply and demand.

We prepared a sensitivity analysis of our exposure to market risk with respect to key raw materials and conversion costs for which we do not possess contractual market price adjustment protections, based on average prices for the first nine months of 2010. We included only those raw materials and conversion costs for which a hypothetical adverse change in price would result in a 1.5% or greater decrease in gross profit. Assuming that the prices of the associated finished goods could not be increased and assuming no change in quantities sold, a hypothetical 10% change in the average price of the commodities listed below would result in the following change in annual gross profit:

(Volumes and dollars in thousands)

| Item | Volume(a) Requirements | Units | Hypothetical Adverse Change in Price | Decrease in Gross Profit | Percentage Decrease in Gross Profit |
| --- | ---: | --- | ---: | ---: | ---: |
| Biodiesel feedstock | 47,245,494 | LB | 10.0% | $ 1,380 | 5.3% |

(a) Volume requirements and average price information are based upon volumes used and prices obtained for the nine months ended September 30, 2010. Volume requirements may differ materially from these quantities in future years as our business evolves.

As of September 30, 2010 and December 31, 2009, we had no borrowings and, as such, were not exposed to interest rate risk.

## Controls and procedures

As filed, 1,136 characters.

Under the supervision and with the participation of our Chief Executive Officer and our Principal Financial Officer and other senior management personnel, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934, as amended (“***Exchange Act”***)) as of the end of the period covered by this report. Based on that evaluation, our Chief Executive Officer and our Principal Financial Officer have concluded that these disclosure controls and procedures as of September 30, 2010 were effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the Securities and Exchange Commission’s rules and forms.

There were no changes in our internal control over financial reporting during our last fiscal quarter that materially affected, or were reasonably likely to materially affect, our internal control over financial reporting.

### PART II

### OTHER INFORMATION

## Risk factors

As filed, 1,876 characters.

See our Form 10-K, Annual Report for the year ended December 31, 2009 filed with the Securities and Exchange Commission on March 15, 2010 for a description of “Risk Factors” relating to an investment in us. There are no material changes from the risk factors disclosed in such filing except as follows.

***The federal excise tax credit for biodiesel expires on December 31, 2009 and to date Congress has not enacted legislation to extend this credit. If the credit expires, our cost of producing biodiesel will be increased, which could have an adverse effect on our financial position.***

In October 2004, Congress passed a biodiesel tax incentive, structured as a federal excise tax credit, as part of the American Jobs Creation Act of 2004. The credit amounts to one cent for each percentage point of biodiesel that is blended with petrodiesel. For example, blenders that blend B20 receive a 20¢ per gallon excise tax credit. The tax incentive generally is taken by petroleum distributors and is passed on to the consumer. It is designed to lower the cost of biodiesel to consumers in both taxable and tax-exempt markets. The tax credit was scheduled to expire at the end of 2006, but was extended in the Energy Policy Act of 2005 to December 31, 2008 and most recently it was extended to December 31, 2009.

To date, Congress has not enacted any legislation to extend this tax credit beyond December 31, 2009. If the tax credit is not extended, our biodiesel production costs will increase by $1.00 per gallon. If biodiesel feedstock costs do not decrease significantly relative to biodiesel prices, or if federal mandates for biodiesel usage do not have the effect of increasing prices for biodiesel, we would realize a negative biodiesel production margin. As a result, we would cease producing biodiesel, which could have an adverse effect on our financial condition.

Filed Nov 5, 2010.
Source: SEC EDGAR, the filing index for accession 0001068800-10-000094. Last ingested by Listed: Nov 14, 2026, 19:59 ET. No prices; not investment advice.
